FDA Chief: Doctors Can Make Own Decisions About Hydroxychloroquine
While Stephen Hahn says the FDA is not in a position to "regulate the practice of medicine," a group of researchers oppose doctors prescribing the anti-malarial drug for COVID.
The Hill:
FDA Chief: Hydroxychloroquine Use A Decision Between Doctor And Patient
Stephen Hahn, the commissioner of the Food and Drug Administration (FDA), on Thursday declined to take a definitive stance on whether people should take hydroxychloroquine as a treatment for the coronavirus, instead saying that decision should be made between a doctor and a patient. “We had data that when this drug was combined with others, there was some risk associated with that. But the question you’re asking me is a decision between a doctor and a patient,” Hahn said on NBC’s “Today” show. (Axelrod, 7/30)
CNN:
Hydroxychloroquine: Researchers Publish Scathing Critique Of Henry Ford Study Touted By The White House
Researchers on Wednesday published scathing critiques of a study President Trump repeatedly touted on Twitter. That study, published earlier this month in the International Journal of Infectious Diseases, claimed to show that hydroxychloroquine saved lives. President Trump tweeted about it enthusiastically. (Cohen, 7/31)
Kaiser Health News and Politifact HealthCheck:
Don’t Fall For This Video: Hydroxychloroquine Is Not A COVID-19 Cure
Millions of people, including the president of the United States, have seen or shared a video in which a doctor falsely claims there is a cure for the coronavirus, and it’s a medley starring hydroxychloroquine. The video shows several doctors in white coats giving a press conference outside the Supreme Court in Washington, D.C. It persists on social media despite bans from Facebook, Twitter and YouTube, and it was published by Breitbart, a conservative news site. (Funke, 7/31)
Also —
The Hill:
Ohio Pharmacy Board Backtracks, Withdraws Rule Barring Use Of Hydroxychloroquine To Treat Coronavirus
The State of Ohio Board of Pharmacy on Thursday withdrew a rule that would have barred pharmacists, licensed distributors of drugs and medical institutions from prescribing the controversial anti-malaria drug hydroxychloroquine to treat or prevent the novel coronavirus after Gov. Mike DeWine (R) voiced concerns. The state pharmacy board said in a memo on Wednesday that the rule would, in general, prohibit the use of hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19... But the rule quickly met with pushback from DeWine (R), who urged the state board to reconsider the decision the day it went into effect. (Wise, 7/30)
